Zobrazeno 1 - 10
of 20
pro vyhledávání: '"N. Svergun"'
Publikováno v:
Vìsnik: Kiïvsʹkij Nacìonalʹnij Unìversitet Imenì Tarasa Ševčenka. Bìologìâ, Vol 69, Iss 1, Pp 76-79 (2016)
The article describes the phenotypic and functional properties of human dendritic cells generated after treatment with cytotoxic lectins B. subtilis B-7025.
Externí odkaz:
https://doaj.org/article/3bf1e8dcdd214b7a8649a53c9078e5df
Autor:
Tetiana Skrypets, O. Skachkova, I. Kriachok, N. Svergun, N. Khranovska, Ian Pastushenko, I. Tytorenko, O. Gorbach, O. Novosad, T. Kadnikova
Publikováno v:
Annals of Oncology. 29:viii364
Publikováno v:
European Journal of Cancer. 61:S10-S11
Autor:
Irina Kryachok, O. Skachkova, K. Filonenko, A.V. Martynchyk, I. Tytorenko, I. Stepanishyna, N. Svergun, O. Novosad, N. Khranovska, O. Nevdakh, Tetiana Skrypets, O. Gorbach, K. Ulianchenko
Publikováno v:
Annals of Oncology. 27:vi318
Autor:
James T. Rutka, C. Smith, S. Agnihotri, A. Luck, N. Svergun, B. Golbourn, U. Shahzad, C. Figueiredo
Publikováno v:
European Journal of Cancer. 61:S47
Publikováno v:
European Journal of Cancer. 51:S15
Publikováno v:
Annals of Oncology. 25:vi3
Introduction Lack of effectiveness of most immunotherapy methods requires new approaches. One of the most promising approaches, intensively investigated worldwide, is combined therapy based on dendritic cells (DC) and low-dose chemotherapy. The using
Publikováno v:
Annals of Oncology. 25:iv557
Aim: Combined therapy based on dendritic cells (DC) and low-dose chemotherapy is being intensively investigated worldwide. The using of low-dose chemotherapy, such as cyclophosphamide, reduces the number of T-regulatory cells, which in turn decreases
Publikováno v:
Annals of Oncology. 25:iv532
Aim: The aim of the study was to analyze the risk factors of cardiac toxicity (CT), to extract the group of high risk of CT development and implement the preventive treatment of CT in this group. Methods: In 146 patients with breast cancer who receiv